Andrew S. Davis - Dec 1, 2022 Form 4 Insider Report for Silk Road Medical Inc (SILK)

Role
Chief Commercial Officer
Signature
/s/Mhairi Jones, by power of attorney
Stock symbol
SILK
Transactions as of
Dec 1, 2022
Transactions value $
-$347,452
Form type
4
Date filed
12/2/2022, 05:40 PM
Previous filing
Nov 1, 2022
Next filing
Jan 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SILK Common Stock Options Exercise $3.63K +2.49K +2.53% $1.46* 101K Dec 1, 2022 Direct F1
transaction SILK Common Stock Sale -$132K -2.49K -2.47% $53.00 98.2K Dec 1, 2022 Direct F1
transaction SILK Common Stock Options Exercise $6.83K +4.27K +4.34% $1.60* 102K Dec 1, 2022 Direct F1
transaction SILK Common Stock Sale -$226K -4.27K -4.16% $53.00 98.2K Dec 1, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SILK Option (right to buy) Options Exercise $0 -2.49K -100% $0.00* 0 Dec 1, 2022 Common Stock 2.49K $1.46 Direct F1, F2
transaction SILK Option (right to buy) Options Exercise $0 -4.27K -13.56% $0.00 27.2K Dec 1, 2022 Common Stock 4.27K $1.60 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on May 20, 2022.
F2 All of the shares subject to this option are fully vested and exercisable as of the date hereof.